Primary Image

plum header

Clinical Trial

Stimulating neuroplasticity in TBI with acute intermittent hypoxia

IRB Protocol Number STU00213969

Contact

Dr. Katya Delikishkina kdelikishk@sralab.org

Objective

We are studying whether briefly reducing oxygen consumption, equivalent to being on top of a mountain, is safe and stimulates neuroplasticity in people who have had a concussion or a mild to moderate traumatic brain injury (TBI). Neuroplasticity indicates that the brain is changing positively to help you function and learn.

The aim of this study is to determine if acute intermittent hypoxia is safe and effective for treating cognitive and motor deficits in TBI patients.

Participation takes approximately 18 hours over the course of six visits to the Shirley Ryan Abilitylab main location in Streeterville.

335 E. Erie Street, Chicago, IL 60611

Compensation

Provided (x)  $20/hour (expected total $360 for six visits)

Age Range

18-65

Apply for this Trial

Your information will not be published.

All fields are required.

Featured Quote

More Studies Like This

Intensive Attention Training To Treat Brain Fog In Individuals With Long-COVID

The goal of this study is to test the feasibility and effectiveness of an attention training intervention as a potential treatment for brain fog symptoms (forgetfulness, confusion, or lack of focus) experienced by people with Long-Covid.

read more
view all

Latest Updates

view all